Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vascular smooth muscle cell (VSMC) proliferation pathway refers to the complex network of molecular signals and cellular events that regulate the growth and division of VSMCs. This process is central to vascular development, repair, and pathology, especially in conditions such as atherosclerosis, restenosis after angioplasty, hypertension, and vascular remodeling. Key signaling pathways involved include NF-κB p65/miR-17/RB, MAPK/ERK, and PI3K/Akt. Upstream stimuli include endothelial injury and the release of cytokines/growth factors. Excessive activation of this pathway contributes to diseases like atherosclerosis and restenosis, making it a therapeutic target.
Inhibition of key signaling components (e.g., MAPK/ERK, PI3K/Akt), cell cycle arrest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular Smooth Muscle Cell Proliferation Pathway (None).